3 terminated, 1 completed, 1 not yet recruiting, 1 withdrawn. 6 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Terminated 3, Completed 1, Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 3 | Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow Allogeneic Stem Cell Transplantation: new trials by email Literature Review of Allogeneic Stem Cell Transplantation trials Research Report on Allogeneic Stem Cell Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of an Investigational Drug After Rejecting the Relapse of an Allogeneic Transplant CARTemis-1 - Multiple Myeloma, Allogeneic Stem Cell Transplantation | Phase 1 / Phase 2 | Not yet recruiting | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 25 | 2024-12-30 | 2024-05-14 |
| A Study of Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant Siremadlin - Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation | Phase 1 / Phase 2 | Terminated | Novartis Pharmaceuticals | 8 | 2023-02-23 | 2025-05-16 |
| Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation Lymphopheresis, CMV specific lymphocyte infusion, Peripheral blood for CMV DNA PCR - CMV Reactivation, Allogeneic Stem Cell Transplantation | Phase 1 / Phase 2 | Withdrawn | Imperial College London | 2011-04-01 | 2015-06-08 | |
| Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. Fludarabine, Melphalan, Antithymocyte Globulin - Hematologic Malignancies, Allogeneic Stem Cell Transplantation | Phase 1 | Completed | Fate Therapeutics | 12 | 2011-01-01 | 2013-10-08 |
| Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant Genotropin (Recombinant Human Growth Hormone) - Allogeneic Stem Cell Transplantation | Phase 1 | Terminated | Mitchell Horwitz, MD | 14 | 2008-09-01 | 2014-03-20 |
| CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease CMV pp65 Specific T Cells - Allogeneic Stem Cell Transplantation | Phase 1 | Terminated | H. Kim Lyerly | 2 | 2005-08-01 | 2012-11-12 |
Hematologic Neoplasms (2) · Leukemia (1) · Leukemia, Myeloid, Acute (1) · Multiple Myeloma (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (3) · Neoplasms by Site (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Myeloid (1) · Lymphoproliferative Disorders (1) · Neoplasms, Plasma Cell (1)
Antilymphocyte Serum (1) · Blood Chemical Analysis (1) · Growth Hormone (1) · Human Growth Hormone (1) · Leukapheresis (1) · Melphalan (1) · Sirolimus (1) · Tacrolimus (1) · fludarabine (1) · siremadlin (1)
Fate Therapeutics (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · H. Kim Lyerly (1) · Imperial College London (1) · Mitchell Horwitz, MD (1) · Novartis Pharmaceuticals (1)
United States (3) · Spain (2) · Germany (1) · Italy (1) · United Kingdom (1)
Corey Cutler, MD, MPH, FRCP(C) (1) · H. Kim Lyerly, M.D. (1) · Jose-Antonio Perez-Simon, MD-PhD (1) · Katy Rezvani, MD (1) · Michael A Morse, M.D. (1) · Mitchell Horwitz, MD (1)